Page last updated: 2024-11-05

tolazoline and Carcinoma, Bronchogenic

tolazoline has been researched along with Carcinoma, Bronchogenic in 1 studies

Tolazoline: A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn.
tolazoline : A member of the class of imidazoles that is 4,5-dihydro-1H-imidazole substituted by a benzyl group.

Carcinoma, Bronchogenic: Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tarkkanen, A1
Merenmies, L1
Mäkinen, J1

Other Studies

1 other study available for tolazoline and Carcinoma, Bronchogenic

ArticleYear
Embolism of the central retinal artery secondary to metastatic carcinoma.
    Acta ophthalmologica, 1973, Volume: 51, Issue:1

    Topics: Anticoagulants; Carcinoma, Bronchogenic; Constriction; Digitalis Glycosides; Embolism; Humans; Ische

1973